BIO GREEN MED SOLUTION INC (BGMS) Stock Price, Forecast & Analysis
USA - NASDAQ:BGMS - US23254L8761 - Common Stock
BGMS Key Statistics, Chart & Performance
The current stock price of BGMS is 1.31 USD. In the past month the price decreased by -67.57%.
BGMS Latest News, Press Relases and Analysis
BGMS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.59 | 410.48B | ||
| AMGN | AMGEN INC | 15.4 | 181.29B | ||
| GILD | GILEAD SCIENCES INC | 15.26 | 155.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.18 | 112.08B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.41 | 73.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 880.71 | 58.88B | ||
| INSM | INSMED INC | N/A | 40.84B | ||
| NTRA | NATERA INC | N/A | 28.04B | ||
| BIIB | BIOGEN INC | 10.01 | 24.56B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.67 | 21.10B | ||
| INCY | INCYTE CORP | 16.22 | 20.34B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 34.66 | 14.37B |
Related stock screener links
About BGMS
Company Profile
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
Company Info
BIO GREEN MED SOLUTION INC
200 Connell Dr Ste 1500
Berkeley Heights NEW JERSEY US
Employees: 0
Phone: 19085177330
BIO GREEN MED SOLUTION INC / BGMS FAQ
What does BIO GREEN MED SOLUTION INC do?
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
What is the current price of BGMS stock?
The current stock price of BGMS is 1.31 USD. The price decreased by -2.24% in the last trading session.
Does BIO GREEN MED SOLUTION INC pay dividends?
BGMS does not pay a dividend.
How is the ChartMill rating for BIO GREEN MED SOLUTION INC?
BGMS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of BGMS stock?
BIO GREEN MED SOLUTION INC (BGMS) operates in the Health Care sector and the Biotechnology industry.
How is the valuation of BIO GREEN MED SOLUTION INC (BGMS) based on its PE ratio?
BIO GREEN MED SOLUTION INC (BGMS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-122.08).
Can you provide the market cap for BIO GREEN MED SOLUTION INC?
BIO GREEN MED SOLUTION INC (BGMS) has a market capitalization of 4.58M USD. This makes BGMS a Nano Cap stock.
BGMS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BGMS.
BGMS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGMS. BGMS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BGMS Financial Highlights
Over the last trailing twelve months BGMS reported a non-GAAP Earnings per Share(EPS) of -122.08. The EPS increased by 96.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -146.13% | ||
| ROE | -177.11% | ||
| Debt/Equity | 0 |
BGMS Forecast & Estimates
For the next year, analysts expect an EPS growth of 39.49% and a revenue growth 88.68% for BGMS